Skip to content

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels Prior to Elective Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04263571
Acronym
PREDICT-IVI
Enrollment
100
Registered
2020-02-11
Start date
2019-04-12
Completion date
2023-12-31
Last updated
2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, IV Iron

Keywords

hemoglobin, hepcidin

Brief summary

The study is a multidisciplinary study, which involves all kind of medical specialties. Patients, who are scheduled for elective surgery, will be seen at a multidisciplinary anaesthesia/Patient Blood Management (PBM) clinic and screened for anaemia prior to surgery. Anaemic patients will eventually be treated with 500mg of iron isomaltoside.

Detailed description

Hgb levels, standard iron parameters and hepcidin will be assessed. Additional parameters that might influence Hgb or IVI levels will be documented. All main analyses will be pre-defined in detail in a statistical analysis plan. In order to analyse the responsiveness to IVI, the change in Hgb levels from PBM clinic to day 0 will be analysed using multivariable regression models. The association of change in Hgb and hepcidin will be analysed adjusting for potentially confounding factors as age, gender or number of days from PBM clinic to surgery. The correlation of hepcidin and standard iron parameters will be assessed. Based on the increase in Hgb levels, responders to IVI will be defined. The definition of good- bad responder in terms of delta Hgb levels depends on the time between IVI substitution and surgery. ROC analyses will be performed and potential predictors (e.g. hepcidin, ferritin) will be compared concerning the area under the ROC curve (AUC).

Interventions

None listed

Sponsors

Pharmacosmos A/S
CollaboratorINDUSTRY
University Hospital Muenster
CollaboratorOTHER
Goethe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* informed consent * iron deficiency anemia * elective surgery planned during the next 4 to 28 days

Exclusion criteria

* Contraindications for an IV iron Infusion severe infections, hepatocellular carcinoma, liver metastases, acute severe asthma, a simultaneous oral iron medication, another IV iron preparation, iron overload, chronic renal failure and regular IV iron substitution * Pregnancy or lactation * Allergy against iron * chronic renal failure on dialysis * iron overload

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin level4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic.Change in hemoglobin level after IV iron treatment

Secondary

MeasureTime frameDescription
Serum iron4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalSerum iron prior to IV iron
Transferrin saturation4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalTransferrin saturation prior to IV iron
Ferritin levels4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalFerritin levels prior to IV iron
Transferrin protein4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalTransferrin protein prior to IV iron
Soluble transferrin receptor4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalSoluble transferrin receptor prior to IV iron
Number of reticulocyte counts4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalNumber of reticulocyte counts
Mean corpuscular hemoglobin (MCH)4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalMean corpuscular hemoglobin prior to IV iron
Level of reticulocyte-Hb in g/dl4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalLevel of reticulocyte-Hb prior to IV iron
Hepcidin4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic.Serum hepcidin level prior to IV iron Infusion (ng/ml)
Corpuscular hemoglobin of reticulocytes (CHr)4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalCorpuscular hemoglobin of reticulocytes (CHr) prior to IV iron
Leucocyte count4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. value prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalLeucocyte count prior to IV iron Infusion
Level of C-reactive Protein4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. value prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalLevel of C-reactive Protein prior to IV iron Infusion
Level of Serum Procalcitonin4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. value prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalLevel of Serum Procalcitonin prior to IV iron Infusion
Length of stay in the hospitalUp to 12 weeksLength of stay in the hospital
blood transfusionsUp to 12 weeksNumber of blood transfusions
Diagnosis Related Groups (DRGs) related to infectionsUp to 12 weeksDiagnoses encoding infections
Correlation of hepcidin and IV iron parameters4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Correlation of values prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalCorrelation of serum hepcidin and change of Hgb from baseline to day of surgery, day 1, 3 and 7 after surgery and the day of discharge
Level of Phosphate in serum4-28 days prior to elective surgery, IV iron is infused in the anesthesia pre-assessment clinic. Value of each parameter prior to IV iron infusion, prior to surgery, at day 1, 3 and 7 or day of release from hospitalLevel of Phosphate in serum prior to IV iron

Countries

Germany

Contacts

Primary ContactAndrea U Steinbicker, Prof Dr MPH
andrea.steinbicker@kgu.de+49 69630186188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026